National to roll back free prescription fees to pay for 13 cancer treatments

21 August 2023 - The National Party wants to bring back the $5 prescription fee for those who can afford ...

Read more →

PHARMAC proposes widening access to a brain cancer treatment to help reduce the impact of a discontinuation

11 August 2023 - PHARMAC is proposing to widen access to temozolomide, an oral anti-cancer treatment, for people with a type ...

Read more →

Ovarian cancer: Bay of Plenty mother spends more than $130,000 on treatments

12 May 2023 - Four cancer treatments in three years: $132,775. ...

Read more →

New Zealand Pharmaceutical Schedule - 1 April 2023

1 April 2023  The April 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

‘When’s our turn?’ PHARMAC's new funding won't cover breast cancer fighter's $100k bill

13 March 2023 - Hayley Steele has a hefty price tag on her life, one worth almost $100,000. ...

Read more →

PHARMAC funds two new treatments for lung cancer

7 March 2023 - PHARMAC has announced the funding of two new medicines - pembrolizumab (Keytruda) and atezolizumab (Tecentriq) for people ...

Read more →

'Death sentence' for mum with skin cancer without $100k for the drugs she needs

3 March 2023 - Jen Rowlands, 43, faces certain death from terminal cancer without a specific drug that could radically improve ...

Read more →

PHARMAC consulting on two new medicines for lung cancer

16 December 2022 - PHARMAC has reached provisional agreements with two different suppliers to fund two medicines to treat New Zealanders ...

Read more →

Miracle medicines: a cancer specialist sends a message to PHARMAC

11 December 2022 - Let's make one thing crystal clear: effective chemotherapeutic drugs make a tremendous difference to survival outcomes ...

Read more →

The cruellest tax: clipping the ticket on unfunded cancer drugs

28 November 2022 - Jo McKenzie-McLean’s life was turned upside down after a stage 4 bowel cancer diagnosis. ...

Read more →

Kiwi myeloma cancer sufferers don’t have access to daratumumab, a drug available in Australia

21 November 2022 - Kiwi cancer sufferers are being denied a drug that saves lives in other countries, including Australia ...

Read more →

PHARMAC welcomes Myeloma NZ as first patient advocacy group to present to PTAC

21 November 2022 - Myeloma New Zealand presented directly to PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC) on Thursday, making ...

Read more →

Woman who has to pay $115k for unfunded cancer drug asks: 'What price is a life?'

5 November 2022 - More than anything, Annemarie Hope-Cross​​ wants to live. ...

Read more →

New PHARMAC funded drug will help in the cancer battle - but it's still not enough

5 October 2022 - Lung Foundation New Zealand CEO Philip Hope says funding by PHARMAC of a new cancer drug is ...

Read more →

Prostate cancer: Tauranga man spends $212,000 on treatment

24 September 2022 - Five thousand and five hundred dollars every 28 days - more than $200,000 so far. ...

Read more →